CurrentRheuma coverage · page 14 of 14

Lupus

Briefs 521–555 of 555 CurrentRheuma has covered from this journal, newest publication first

Latest from Lupus

All coverage, newest first

Lupus5 Jan 2023
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis
Cohort studyLupus & APS
Lupus4 Jan 2023
Possible relationship between hydroxychloroquine and electrocardiographic and echocardiographic abnormalities in patients with inflammatory rheumatic diseases––a monocentric study
Cross-sectional studyAcross diseases
Lupus4 Jan 2023
The potential causal association of systemic lupus erythematosus with congestive heart failure in the East Asian population: A two-sample mendelian randomization study
Research articleLupus & APS
Lupus3 Jan 2023
The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients
Cohort studyLupus & APS
Lupus27 Dec 2022
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies
Meta-analysisLupus & APS
Lupus23 Dec 2022
Nutritional, biochemical, and clinical determinants of hyperuricemia in systemic lupus erythematosus patients: Relationship with clinical and renal disease activity
Cross-sectional studyLupus & APS
Lupus22 Dec 2022
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis
Meta-analysisLupus & APS
Lupus21 Dec 2022
The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
Cohort studyLupus & APS
Lupus21 Dec 2022
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey
Cross-sectional studyLupus & APS
Lupus20 Dec 2022
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis
Meta-analysisLupus & APS
Lupus14 Dec 2022
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study
Cross-sectional studyLupus & APS
Lupus12 Dec 2022
Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus
Cross-sectional studyLupus & APS
Lupus9 Dec 2022
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study
Cohort studyLupus & APS
Lupus8 Dec 2022
The exploration of shared genes and molecular mechanisms of systemic lupus erythematosus and atherosclerosis
Diagnostic or prognostic studyLupus & APS
Lupus5 Dec 2022
Influencing factors of self-disclosure and its impact on quality of life in patients with systemic lupus erythematosus
Cross-sectional studyLupus & APS
Lupus5 Dec 2022
Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab
Cohort studyLupus & APS
Lupus2 Dec 2022
Pulmonary involvement: A potential independent factor for quality of life in systemic lupus erythematosus
Cross-sectional studyLupus & APS
Lupus2 Dec 2022
Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis
Cohort studyLupus & APS
Lupus2 Dec 2022
Development of an instrument to predict proliferative histological class in lupus nephritis based on clinical and laboratory data
Cohort studyLupus & APS
Lupus30 Nov 2022
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance
Cohort studyLupus & APS
Lupus29 Nov 2022
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort
Cross-sectional studyLupus & APS
Lupus26 Nov 2022
Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection
Case-control studyLupus & APS
Lupus23 Nov 2022
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study
Cohort studyLupus & APS
Lupus23 Nov 2022
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus
Case-control studyLupus & APS
Lupus23 Nov 2022
Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis
Diagnostic or prognostic studyLupus & APS
Lupus22 Nov 2022
Cardiac involvement in a Spanish unicentric prospective cohort of patients with systemic lupus erythematosus
Cohort studyLupus & APS
Lupus18 Nov 2022
Alexithymia in systemic lupus erythematosus: A cross sectional study in a Brazilian sample
Cross-sectional studyLupus & APS
Lupus17 Nov 2022
Association between serum uric acid level and systemic lupus erythematosus kidney outcome: An observational study in Southern Chinese population and a meta-analysis
Meta-analysisLupus & APS
Lupus8 Nov 2022
Adherence to antimalarials and glucocorticoids treatment and its association with self-reported disease activity in systemic lupus erythematosus patients
Cross-sectional studyLupus & APS
Lupus4 Nov 2022
Literature review of lupus nephritis From the Arabian Gulf region
Research articleLupus & APS
Lupus31 Oct 2022
Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus
Mechanistic studyLupus & APS
Lupus28 Oct 2022
U-KIM-1 as a predictor of treatment response in lupus nephritis
Research articleLupus & APS
Lupus27 Oct 2022
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
Cross-sectional studyLupus & APS
Lupus22 Oct 2022
Social determinants of depression in systemic lupus erythematosus: A systematic scoping review
Research articleLupus & APS
Lupus30 Sep 2022
Pilot study on accelerated aging in lupus using epigenetic biomarkers of age
Secondary analysisLupus & APS

All 555 Briefs in ExploreShowing Briefs 521–555 of 555, newest first